Access cutting-edge acute kidney injury treatment through this clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Cincinnati location
Preparing your pre-screening questions…
Access acute kidney injury specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acute kidney injury treatment provided free
Check if you qualify for this acute kidney injury clinical trial in Cincinnati, OH
No-Cost Study Care
Local to Cincinnati
Convenient for OH residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
QUELIMMUNE is FDA-approved under an HDE for the treatment of pediatric patients (weight ≥10kg and age ≤22 years) with AKI due to sepsis or a septic condition on antibiotic therapy and requiring RRT. The purpose of this surveillance registry is to prospectively collect safety data among all patients treated with QUELIMMUNE under the HDE. More specifically, we intend on comparing the incidence of new (secondary) blood stream infections in the first 28 days after SCD-PED initiation to a comparator group of matched CKRT patients with sepsis who did not receive treatment with QUELIMMUNE
Sponsor: SeaStar Medical
Yes, this clinical trial (NCT06517810) has an active research site in Cincinnati, OH that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for acute kidney injury treatment options in Cincinnati, OH, this clinical trial (NCT06517810) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cincinnati research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute kidney injury specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.